Polomar Health Services, Inc. (PMHS) Fair Value 2026

PMHS · Pharmaceutical Retailers ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.2 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (33/100)

Quick Summary — As of 2026-08-27, Polomar Health Services, Inc. (PMHS) trades at $0.30. QOC: 5.2/10. Value Trap Risk: 33/100 (LOW). 0/13 models active.

Key Facts

Ticker
PMHS
Price
$0.30
Quality Score
5.2/10
Value Trap Risk
33/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give PMHS?

0 Intrinsic Value Models vs. Current Price ($0.30)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Polomar Health Services, Inc. (PMHS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Polomar Health Services, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About PMHS?

0 of 13 models are currently active for PMHS. See which stocks rank higher →

How Does PMHS Rank in Pharmaceutical Retailers?

Among 9 Pharmaceutical Retailers stocks, PMHS ranks #7 by Quality of Company score. CirclFi's QOC score of 5.2/10 evaluates 32 fundamental signals. A score of 5.2 reflects mixed fundamentals.

Polomar Health Services, Inc.'s positioning within the Pharmaceutical Retailers segment means that pipeline depth and stage distribution plays an outsized role in fundamental analysis. The sector's unique characteristics — including licensing and M&A optionality — shape both the opportunity set and risk profile.

Is PMHS a Value Trap?

CirclFi's Value Trap algorithm assigns PMHS a score of 33/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Polomar Health Services, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Polomar Health Services, Inc. earns a quality score of 5.2/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PMHS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Polomar Health Services, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Pharmaceutical Retailers Stocks Should You Also Analyze?

8 related Pharmaceutical Retailers stocks with 13-model coverage

BHICBioScience Health Innovations IQOC 6.8PETSPetMed Express, Inc.QOC 6.2HITIHigh Tide Inc.QOC 5.8SHFHScientist Home Future Health LimitedQOC 5.6DHTIDalrada Technology Group Inc.QOC 5.4SCNXScienture Holdings, Inc.QOC 5.2POMPomdoctor LimitedQOC 4.9RDGTRidgetech, Inc.QOC 1.8

Read investment analysis: BHIC · PETS · HITI · SHFH · DHTI · SCNX · POM · RDGT

Which Other Stocks Have a Similar Quality Score to PMHS?

6 companies across all industries closest to PMHS’s Quality of Company score of 5.2/10.

ALDXAldeyra Therapeutics, Inc.QOC 5.2MCIBarings Corporate InvestorsQOC 5.2NEUPNeuphoria Therapeutics Inc.QOC 5.2SCLXScilex Holding CompanyQOC 5.2MREOMereo BioPharma Group plcQOC 5.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: ALDX · MCI · NEUP · SCLX · MREO · NVDA

What Else Do Investors Ask About Polomar Health Services, Inc.’s Valuation?

What is Polomar Health Services, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Polomar Health Services, Inc. (PMHS). The Quality of Company score is 5.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PMHS overvalued or undervalued right now?

At $0.30, 0 of 0 active models suggest PMHS may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Polomar Health Services, Inc.'s business model in Pharmaceutical Retailers.

What does a Quality of Company score of 5.2 mean for PMHS?

Polomar Health Services, Inc.'s QOC of 5.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on PMHS?

CirclFi analyzes PMHS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is PMHS a value trap in 2026?

Polomar Health Services, Inc.'s Value Trap score is 33/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Polomar Health Services, Inc. (PMHS) a Quality of Company score of 5.2/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/PMHS/ · Methodology
Primary sources for this PMHS valuation
  • Financial statements: Polomar Health Services, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001265521) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for PMHS as of ; valuations recomputed .